814 related articles for article (PubMed ID: 17270507)
21. Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways.
Bridle KR; Popa C; Morgan ML; Sobbe AL; Clouston AD; Fletcher LM; Crawford DH
Liver Transpl; 2009 Oct; 15(10):1315-24. PubMed ID: 19790156
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and pathological analysis on characteristics of primary biliary cirrhosis].
Zhou GD; Zhao JM; Wang SS; Sun YL; Meng EH; Zhang TH; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):483-6. PubMed ID: 12939182
[TBL] [Abstract][Full Text] [Related]
23. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression.
Degott C; Zafrani ES; Callard P; Balkau B; Poupon RE; Poupon R
Hepatology; 1999 Apr; 29(4):1007-12. PubMed ID: 10094939
[TBL] [Abstract][Full Text] [Related]
24. The pathology of cholestasis.
Li MK; Crawford JM
Semin Liver Dis; 2004 Feb; 24(1):21-42. PubMed ID: 15085484
[TBL] [Abstract][Full Text] [Related]
25. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; Weltman MD; Tilg H; Moschen AR; Purdie DM; Demetris AJ; Clouston AD
Gastroenterology; 2007 Jul; 133(1):80-90. PubMed ID: 17631134
[TBL] [Abstract][Full Text] [Related]
26. The pathology of primary biliary cirrhosis and autoimmune cholangitis.
Ludwig J
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):601-13. PubMed ID: 10976017
[TBL] [Abstract][Full Text] [Related]
27. Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis.
Onori P; Alvaro D; Floreani AR; Mancino MG; Franchitto A; Guido M; Carpino G; De Santis A; Angelico M; Attili AF; Gaudio E
J Histochem Cytochem; 2007 Apr; 55(4):327-34. PubMed ID: 17164408
[TBL] [Abstract][Full Text] [Related]
28. [Clinico-immunological profile of hepatic and extrahepatic diseases accompanied by anti-mitochondrial antibodies].
Chevailler A; Saint-André JP; Préel JL; Boyer J; Joubaud F; Hurez D
Ann Med Interne (Paris); 1988; 139(1):19-23. PubMed ID: 3364874
[TBL] [Abstract][Full Text] [Related]
29. Factors predicting advanced hepatic fibrosis in patients with postcholecystectomy bile duct strictures.
Negi SS; Sakhuja P; Malhotra V; Chaudhary A
Arch Surg; 2004 Mar; 139(3):299-303. PubMed ID: 15006888
[TBL] [Abstract][Full Text] [Related]
30. Hepatic sarcoidosis. Clinicopathologic features in 100 patients.
Devaney K; Goodman ZD; Epstein MS; Zimmerman HJ; Ishak KG
Am J Surg Pathol; 1993 Dec; 17(12):1272-80. PubMed ID: 8238735
[TBL] [Abstract][Full Text] [Related]
31. ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults.
Ziol M; Barbu V; Rosmorduc O; Frassati-Biaggi A; Barget N; Hermelin B; Scheffer GL; Bennouna S; Trinchet JC; Beaugrand M; Ganne-Carrié N
Gastroenterology; 2008 Jul; 135(1):131-41. PubMed ID: 18482588
[TBL] [Abstract][Full Text] [Related]
32. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis.
Gómez-Dominguez E; Mendoza J; García-Buey L; Trapero M; Gisbert JP; Jones EA; Moreno-Otero R
Aliment Pharmacol Ther; 2008 Mar; 27(5):441-7. PubMed ID: 18081731
[TBL] [Abstract][Full Text] [Related]
33. Pipe-3D: A Pipeline Based on Immunofluorescence, 3D Confocal Imaging, Reconstructions, and Morphometry for Biliary Network Analysis in Cholestasis.
Damle-Vartak A; Begher-Tibbe B; Gunther G; Geisler F; Vartak N; Hengstler JG
Methods Mol Biol; 2019; 1981():25-53. PubMed ID: 31016646
[TBL] [Abstract][Full Text] [Related]
34. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.
Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Ferri S; Quarneti C; Cipriano V; de Molo C; Lenzi M; Chapman RW; Bianchi FB
Aliment Pharmacol Ther; 2007 Sep; 26(6):831-8. PubMed ID: 17767467
[TBL] [Abstract][Full Text] [Related]
35. Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
Elßner C; Goeppert B; Longerich T; Scherr AL; Stindt J; Nanduri LK; Rupp C; Kather JN; Schmitt N; Kautz N; Breuhahn K; Ismail L; Heide D; Hetzer J; García-Beccaria M; Hövelmeyer N; Waisman A; Urbanik T; Mueller S; Gdynia G; Banales JM; Roessler S; Schirmacher P; Jäger D; Schölch S; Keitel V; Heikenwalder M; Schulze-Bergkamen H; Köhler BC
Gastroenterology; 2019 Mar; 156(4):1190-1205.e14. PubMed ID: 30445013
[TBL] [Abstract][Full Text] [Related]
36. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
[TBL] [Abstract][Full Text] [Related]
37. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis.
Wang AP; Migita K; Ito M; Takii Y; Daikoku M; Yokoyama T; Komori A; Nakamura M; Yatsuhashi H; Ishibashi H
J Autoimmun; 2005 Aug; 25(1):85-91. PubMed ID: 16006099
[TBL] [Abstract][Full Text] [Related]
38. GFAP expression in the liver as an early marker of stellate cells activation.
Morini S; Carotti S; Carpino G; Franchitto A; Corradini SG; Merli M; Gaudio E
Ital J Anat Embryol; 2005; 110(4):193-207. PubMed ID: 16536051
[TBL] [Abstract][Full Text] [Related]
39. Relationship between plasma cells and hepatic stellate cells in autoimmune hepatitis.
Brandão DF; Ramalho FS; Martinelli AL; Zucoloto S; Ramalho LN
Pathol Res Pract; 2010 Dec; 206(12):800-4. PubMed ID: 20926203
[TBL] [Abstract][Full Text] [Related]
40. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts.
Guido M; Rugge M; Leandro G; Fiel IM; Thung SN
Hepatology; 1997 Aug; 26(2):310-4. PubMed ID: 9252139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
